Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659. Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659.
Kuehn Law Encourages PRMW, FBMS, EVRI, and LBPH Investors to Contact Law Firm PR Newswire NEW YORK, Oct. 15, 2024 NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Longboard Pharmaceuticals, Inc. PR Newswire NEW YORK, Oct. 14, 2024 NEW YORK, Oct. 14, 2024 /PRNewswire/ -- Rowley Law PLLC is...
The proposed acquisition represents a significant step forward in Lundbeck’s Focused Innovator strategy, adding a highly innovative and complementary product in late-stage development for...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the...
First sites activated with a number of additional rapid-start sites being activated in the coming weeks Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company...
U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation and Rare Pediatric Disease designation for bexicaserin for the treatment of Dravet syndrome Longboard Pharmaceuticals...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.32 | -0.537273337811 | 59.56 | 59.95 | 58.82 | 837206 | 59.66932026 | CS |
4 | 23.08 | 63.8274336283 | 36.16 | 59.95 | 32.56 | 3740878 | 57.88724197 | CS |
12 | 23.45 | 65.521095278 | 35.79 | 59.95 | 27.35 | 1705171 | 51.86804791 | CS |
26 | 37.69 | 174.895591647 | 21.55 | 59.95 | 15.64 | 1067368 | 46.40138399 | CS |
52 | 53.82 | 992.988929889 | 5.42 | 59.95 | 3.6 | 968516 | 35.72791382 | CS |
156 | 52.23 | 745.078459344 | 7.01 | 59.95 | 2.7 | 348572 | 33.30719069 | CS |
260 | 43.24 | 270.25 | 16 | 59.95 | 2.7 | 296283 | 32.53311218 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約